The role of TGF-β and myofibroblasts in the arteritis of Kawasaki disease.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Human Pathology

• Publication date

  2013-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.humpath.2012.05.004PMID 22955109PMCID PMC3518690
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Noncanonical TGFβ Signaling Contributes to Aortic Aneurysm Progression in Marfan Syndrome Mice

  2012cited by this paper
• Inhibition of transforming growth factor β worsens elastin degradation in a murine model of Kawasaki disease.

  2011cited by this paper
• Transforming growth factor-beta signaling pathway in patients with Kawasaki disease.

  2011influential reference
• Genome-wide linkage and association mapping identify susceptibility alleles in ABCC4 for Kawasaki disease

  2011cited by this paper
• Noncanonical TGFβ Signaling Contributes to Aortic Aneurysm Progression in Marfan Syndrome Mice

  2011cited by this paper
• Smad3 Signaling Critically Regulates Fibroblast Phenotype and Function in Healing Myocardial Infarction

  2010cited by this paper
• Memory T-cells and characterization of peripheral T-cell clones in acute Kawasaki disease

  2010cited by this paper
• Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2008)--digest version.

  2010cited by this paper
• IL-17 and IL-22: siblings, not twins.

  2010cited by this paper
• Angiotensin II Blockade and Aortic-Root Dilation in Marfan's Syndrome

  2010cited by this paper
• Guidelines for Diagnosis and Management of Cardiovascular Sequelae in Kawasaki Disease (JCS 2008) : Digest Version

  2010cited by this paper
• De Novo Generation and Enhanced Suppression of Human CD4+CD25+ Regulatory T Cells by Retinoic Acid1

  2009cited by this paper
• Differential Regulation of Foxp3 and IL-17 Expression in CD4 T Helper Cells by IRAK-11

  2009cited by this paper
• Non-Smad pathways in TGF-β signaling

  2009cited by this paper
• The basics of epithelial-mesenchymal transition.

  2009cited by this paper
• Multidrug resistance-associated protein 4 regulates cAMP-dependent signaling pathways and controls human and rat SMC proliferation.

  2008cited by this paper
• Resistance to intravenous immunoglobulin in children with Kawasaki disease.

  2008cited by this paper
• Angiotensin II blockade and aortic-root dilation in Marfan's syndrome.

  2008cited by this paper
• ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms

  2008cited by this paper
• The myofibroblast: one function, multiple origins.

  2007cited by this paper
• Subepithelial Myofibroblasts are Novel Nonprofessional APCs in the Human Colonic MucosaSaada JI, Pinchuk IV, Barrera CA, et al (Univ of Texas, Galveston) J Immunol 177:5968–5979, 2006§

  2007cited by this paper
• Activated myeloid dendritic cells accumulate and co-localize with CD3+ T cells in coronary artery lesions in patients with Kawasaki disease.

  2007cited by this paper
• Subepithelial Myofibroblasts are Novel Nonprofessional APCs in the Human Colonic Mucosa1

  2006cited by this paper
• TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells.

  2006cited by this paper
• Neutrophilic involvement in the damage to coronary arteries in acute stage of Kawasaki disease

  2005cited by this paper
• Kawasaki syndrome.

  2004cited by this paper
• Immunohistochemical study of apparently intact coronary artery in a child after Kawasaki disease

  2004cited by this paper
• Histopathological features of murine systemic vasculitis caused by Candida albicans extract – an animal model of Kawasaki Disease

  2004cited by this paper
• Superantigenic activity is responsible for induction of coronary arteritis in mice: an animal model of Kawasaki disease.

  2003cited by this paper
• Mechanisms of Neointima Formation and Remodeling in the Porcine Coronary Artery

  2001cited by this paper
• Myofibroblasts: paracrine cells important in health and disease.

  2000cited by this paper
• Myofibroblasts. I. Paracrine cells important in health and disease.

  1999cited by this paper
• Powell, D. W. et al. Myofibroblasts. I. Paracrine cells important in health and disease. Am. J. Physiol. 277, C1-C9

  1999cited by this paper
• Water transport revisited

  1999cited by this paper
• Differentiation of smooth muscle cells in human blood vessels as defined by smoothelin, a novel marker for the contractile phenotype.

  1997cited by this paper
• Mesenchymal cells stimulate human intestinal intraepithelial lymphocytes.

  1997cited by this paper
• A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome.

  1991cited by this paper
• Class II major histocompatibility antigen expression on coronary arterial endothelium in a patient with Kawasaki disease.

  1990cited by this paper
• Kawasaki syndrome.

  1990cited by this paper
• Myofibroblasts from diverse pathologic settings are heterogeneous in their content of actin isoforms and intermediate filament proteins.

  1989cited by this paper

• Cyclosporine Treatment in Patients with Kawasaki Disease and Coronary Artery Aneurysms or Treatment Resistance.

  2025cites this paper
• The potential role of endothelial cells in the pathophysiology, diagnosis and management of acute Kawasaki disease

  2025cites this paper
• Kawasaki Disease Vasculitis: From Diagnosis to New Concepts in Pathophysiology and Therapeutic Approaches.

  2025cites this paper
• Pathology of the Coronary Arteries and Myocardium in Kawasaki Disease.

  2025cites this paper
• Mapping Drivers of Coronary Endothelial Activation and Endothelial‐to‐Mesenchymal Transition through Mimicking of Multimediator Inflammation in Kawasaki Disease Context

  2025cites this paper
• mTOR signalling controls the formation of smooth muscle cell-derived luminal myofibroblasts during vasculitis

  2024cites this paper
• The Future of Kawasaki Disease Diagnosis: Liquid Biopsy May Hold the Key

  2024cites this paper
• Candesartan Attenuates Vasculitis in a Mouse Model of Kawasaki Disease Induced by Candida albicans Water-Soluble Fraction.

  2024cites this paper
• Platelets in Kawasaki disease: mediators of vascular inflammation

  2024cites this paper
• Genetic Susceptibility to Kasasaki Disease and Biomarkers for the Clinic Diagnosis

  2024cites this paper
• Immune control in Kawasaki disease knowledge mapping: a bibliometric analysis

  2024cites this paper
• Endothelial Dysfunction: Molecular Mechanisms and Therapeutic Strategies in Kawasaki Disease

  2024cites this paper
• Involvement of USP7 in aggravating Kawasaki disease by promoting TGFβ2 signaling mediated endothelial-mesenchymal transition and coronary artery remodeling.

  2024cites this paper
• Platelet–Monocyte Aggregate Instigates Inflammation and Vasculopathy in Kawasaki Disease

  2024cites this paper
• Update on Diagnosis and Management of Kawasaki Disease: A Scientific Statement From the American Heart Association.

  2024cites this paper
• Clinical Signs of Kawasaki Disease from the Perspective of Epithelial-to-Mesenchymal Transition Recruiting Erythrocytes: A Literature Review

  2023cites this paper
• Symptom-correlated MiRNA signature as a potential biomarker for Kawasaki disease

  2023cites this paper
• Endothelial Cell Response in Kawasaki Disease and Multisystem Inflammatory Syndrome in Children

  2023cites this paper
• Multisystem Inflammatory Syndrome in Children and Kawasaki Disease: A Spectrum of Postinfectious Hyperinflammatory Disease.

  2023cites this paper
• Heart Transplant, Kawasaki Disease, and Bone Marrow Transplant: Are There Consequences?

  2022cites this paper
• MicroRNAs in Kawasaki disease: An update on diagnosis, therapy and monitoring

  2022cites this paper
• Association of miR-181c/d gene locus rs8108402 C/T polymorphism with susceptibility to Kawasaki disease in Chinese children

  2022cites this paper
• Molecular mechanisms of endothelial dysfunction in Kawasaki-disease-associated vasculitis

  2022cites this paper
• RNA Sequencing Reveals Beneficial Effects of Atorvastatin on Endothelial Cells in Acute Kawasaki Disease

  2022cites this paper
• Pathogenic and therapeutic roles of cytokines in Kawasaki diseases.

  2022cites this paper
• Association of SNP (rs1042579) in thrombomodulin gene and plasma thrombomodulin level in North Indian children with Kawasaki disease

  2022cites this paper
• Circulating microRNAs in patients with aneurysmal dilatation of coronary arteries

  2022cites this paper
• The Th17 Pathway in Vascular Inflammation: Culprit or Consort?

  2022cites this paper
• CircRNA-3302 promotes endothelial-to-mesenchymal transition via sponging miR-135b-5p to enhance KIT expression in Kawasaki disease

  2022cites this paper
• Biomarkers of inflammation and fibrosis in young adults with history of Kawasaki disease

  2021cites this paper
• Kawasaki Disease

  2021influential citation
• Inhibition of IL-6 in the LCWE Mouse Model of Kawasaki Disease Inhibits Acute Phase Reactant Serum Amyloid A but Fails to Attenuate Vasculitis

  2021cites this paper
• Application of C-reactive Protein/Albumin Ratio (CAR) in Kawasaki Disease

  2021cites this paper
• Epigenetics in Kawasaki Disease

  2021cites this paper
• Identifying Circulating MicroRNA in Kawasaki Disease by Next-Generation Sequencing Approach

  2021cites this paper
• Soluble LR11 as a Novel Biomarker in Acute Kawasaki Disease.

  2021cites this paper
• Gasotransmitters: Potential Therapeutic Molecules of Fibrotic Diseases

  2021cites this paper
• Falling Through the Cracks: The Current Gap in the Health Care Transition of Patients With Kawasaki Disease

  2021cites this paper
• Insights Into Coronary Artery Lesions in Kawasaki Disease

  2020cites this paper
• Sudden death of a young adult with coronary artery vasculitis, coronary aneurysms, parvovirus B19 infection and Kawasaki disease

  2020cites this paper
• A framework for understanding Kawasaki disease pathogenesis.

  2020cites this paper
• The Impact of Moderate-Dose Acetylsalicylic Acid in the Reduction of Inflammatory Cytokine and Prevention of Complication in Acute Phase of Kawasaki Disease: The Benefit of Moderate-Dose Acetylsalicylic Acid

  2020cites this paper
• Use of Adjunctive Therapy in Acute Kawasaki Disease in Latin America

  2020cites this paper
• Biomarkers for Kawasaki Disease: Clinical Utility and the Challenges Ahead

  2019cites this paper
• The association between asthma and Kawasaki disease

  2019cites this paper
• Circulating Markers of Inflammation Persist in Children and Adults With Giant Aneurysms After Kawasaki Disease

  2019cites this paper
• Interleukin 10 and Transforming Growth Factor Beta Polymorphisms as Risk Factors for Kawasaki Disease: A Case-Control Study and Meta-Analysis

  2019cites this paper
• Phase I/IIa Trial of Atorvastatin in Patients with Acute Kawasaki Disease with Coronary Artery Aneurysm.

  2019cites this paper
• A critical appraisal of the role of intracellular Ca2+-signaling pathways in Kawasaki disease.

  2018cites this paper
• miR-27b Suppresses Endothelial Cell Proliferation and Migration by Targeting Smad7 in Kawasaki Disease

  2018cites this paper
• Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase

  2018cites this paper
• miR-186, a serum microRNA, induces endothelial cell apoptosis by targeting SMAD6 in Kawasaki disease

  2018cites this paper
• Gain-of-function STAT1 mutations are associated with intracranial aneurysms.

  2017cites this paper
• Review: Found in Translation: International Initiatives Pursuing Interleukin‐1 Blockade for Treatment of Acute Kawasaki Disease

  2017cites this paper
• Urotensin 2 in Kawasaki disease pathogenesis

  2017cites this paper
• miR-483 Targeting of CTGF Suppresses Endothelial-to-Mesenchymal Transition: Therapeutic Implications in Kawasaki Disease

  2017cites this paper
• Pseudo-normalization of a coronary artery aneurysm detected by IVUS

  2017cites this paper
• Adjunctive therapies in Kawasaki disease

  2017influential citation
• Future Directions in Kawasaki Disease Research

  2017cites this paper
• Pathogenetic determinants in Kawasaki disease: the haematological point of view

  2017cites this paper
• Effect of pirfenidone on cardiac complications in a model of Kawasaki disease in female Balb/C Mice: Histological and Immunohistochemical study

  2017cites this paper
• OF THE WEEK Kawasaki Disease

  2016influential citation
• Genetic variants of ADAM17 are implicated in the pathological process of Kawasaki disease and secondary coronary artery lesions via the TGF-β/SMAD3 signaling pathway

  2016cites this paper
• Serum Tenascin-C as a Novel Predictor for Risk of Coronary Artery Lesion and Resistance to Intravenous Immunoglobulin in Kawasaki Disease　- A Multicenter Retrospective Study.

  2016cites this paper
• TOPIC OF THE WEEK Kawasaki Disease

  2016influential citation
• Genetic Variation in the SLC8A1 Calcium Signaling Pathway Is Associated With Susceptibility to Kawasaki Disease and Coronary Artery Abnormalities

  2016cites this paper
• Found in Translation : International initiatives pursuing interleukin-1 blockade for treatment of acute Kawasaki Disease

  2016cites this paper
• The transcriptional profile of coronary arteritis in Kawasaki disease

  2015cites this paper
• The role of statins in inflammatory vasculitides

  2015cites this paper
• Cardiovascular pathology in 2 young adults with sudden, unexpected death due to coronary aneurysms from Kawasaki disease in childhood.

  2015cites this paper
• Role of TGF-β Signaling in Remodeling of Noncoronary Artery Aneurysms in Kawasaki Disease

  2015cites this paper
• The immunomodulatory effects of intravenous immunoglobulin therapy in Kawasaki disease

  2015cites this paper
• Galectin-3 is a marker of myocardial and vascular fibrosis in Kawasaki disease patients with giant aneurysms.

  2015influential citation
• Evaluating a novel treatment for coronary artery inflammation in acute Kawasaki disease: a Phase I/IIa trial of atorvastatin

  2015cites this paper
• Update on etio and immunopathogenesis of Kawasaki disease

  2014cites this paper
• Transcriptional regulation by infliximab therapy in kawasaki disease patients with immunoglobulin resistance

  2014cites this paper
• Global gene expression profiling identifies new therapeutic targets in acute Kawasaki disease

  2014cites this paper
• Title Global gene expression profiling identifies new therapeutic targets in acute Kawasaki disease Permalink

  2014cites this paper
• T lymphocytes and aortic aneurysms

  2014cites this paper
• Association Between SRC‐1 Gene Polymorphisms and Coronary Artery Aneurysms Formation in Taiwanese Children With Kawasaki Disease

  2014cites this paper
• Prediction of the risk of coronary arterial lesions in Kawasaki disease by serum 25-hydroxyvitamin D3

  2014cites this paper
• Kawasaki Disease.

  2013cites this paper
• Differential Expression of miR-145 in Children with Kawasaki Disease

  2013cites this paper
• Kawasaki disease: part I. Diagnosis, clinical features, and pathogenesis.

  2013influential citation
• Genetics insights into the pathogenesis of Kawasaki disease.

  2012cites this paper